Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes Review

Ng, Hooi Hooi, Leo, Chen Huei, Parry, Laura J et al. (2018). Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes . Frontiers in Pharmacology, 9 10.3389/fphar.2018.00501

Open Access International Collaboration

cited authors

  • Ng, Hooi Hooi; Leo, Chen Huei; Parry, Laura J; Ritchie, Rebecca H

sustainable development goals

authors

publication date

  • May 15, 2018

published in

keywords

  • ACTIVATED RECEPTOR-GAMMA
  • ANGIOTENSIN-II PRODUCTION
  • CARDIAC RESYNCHRONIZATION THERAPY
  • HIGH GLUCOSE
  • HIGH-FAT DIET
  • INDUCED ENDOTHELIAL DYSFUNCTION
  • Life Sciences & Biomedicine
  • NITRIC-OXIDE SYNTHASE
  • PREGNANCY HORMONE RELAXIN
  • Pharmacology & Pharmacy
  • RECOMBINANT HUMAN RELAXIN
  • SPONTANEOUSLY HYPERTENSIVE-RATS
  • Science & Technology
  • cardiomyopathy
  • diabetes
  • endothelial dysfunction
  • relaxin
  • remodeling
  • vasculopathy

Digital Object Identifier (DOI)

volume

  • 9